On Aug. 10, the FDA ruled to reject copyright for assisted psychotherapy for PTSD, citing inadequate proof and the necessity for more study. The ruling is consistent with a letter APA despatched the FDA earlier this yr that said that a review on the literature on copyright-assisted psychotherapy by a multidisciplinary panel of industry experts deci